Cosyntropin .25 mg/mL

Cosyntropin .25 mg/mL is a lyophilized powder for solution, used for diagnostic purposes in assessing adrenal function. This intravenous injection is manufactured by Sandoz Inc in the USA.

Cosyntropin .25 mg/mL is primarily used to evaluate adrenal gland function. It stimulates the adrenal cortex to produce cortisol, helping healthcare providers diagnose conditions related to adrenal insufficiency. This medication is often used in diagnostic tests to determine how well the adrenal glands are working.

When administered, Cosyntropin .25 mg/mL can stimulate the adrenal glands to produce cortisol. This can help identify if the adrenal glands are functioning properly or if there is a deficiency. The effects are typically observed through blood tests that measure cortisol levels.

Cosyntropin .25 mg/mL should be handled with care and administered by healthcare professionals. It is important to follow proper procedures for reconstitution and administration to ensure safety. Patients should inform their healthcare provider about any allergies or medical conditions before use.

Cosyntropin .25 mg/mL may interact with other medications that affect adrenal function. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Always follow the advice of a healthcare professional regarding the use of this medication.